Cardiac myocytes have been traditionally regarded as terminally differentiated cells that adapt
to increased work and compensate for disease exclusively through hypertrophy. However…

The cytokine erythropoietin (Epo) is tissue-protective in preclinical models of ischemic, traumatic,
toxic, and inflammatory injuries. We have recently characterized Epo derivatives that do …

Stimulation of the local renin-angiotensin system and apoptosis characterize the diabetic
heart. Because IGF-1 reduces angiotensin (Ang) II and apoptosis, we tested whether …

To determine whether myocyte death and angiotensin II (AT II) formation are implicated in
the development of diabetic cardiomyopathy, rats were injected with streptozotocin, and …

To determine whether enzymatic p53 glycosylation leads to angiotensin II formation
followed by p53 phosphorylation, prolonged activation of the renin-angiotensin system, and …

Amyotrophic lateral sclerosis is the most common motor neuron disease and is still incurable.
The mechanisms leading to the selective motor neuron vulnerability are still not known. …

The cytokine erythropoietin (EPO) protects the heart from ischemic injury, in part by preventing
apoptosis. However, EPO administration can also raise the hemoglobin concentration, …

Diabetes and oxidative stress concur to cardiac myocyte death in various experimental
settings. We assessed whether N-acetyl-l-cysteine (NAC), an antioxidant and glutathione …

Alzheimer's disease is characterized by the accumulation and deposition of plaques of β-amyloid
(Aβ) peptide in the brain. Given its pivotal role, new therapies targeting Aβ are in …

Engineered nanoparticles offer the chance to improve drug transport and delivery through
biological barriers, exploiting the possibility to leave the blood circulation and traverse the …